The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Erythropoietin Drug-Global Market Insights and Sales Trends 2024
Synopsis
Erythropoietin drugs are also known as hematopoietin. It is a glycoprotein hormone that controls erythropoiesis or production of RBC. They are used in treatment of different diseases like cancer, chronic renal diseases,
The global Erythropoietin Drug market size is expected to reach US$ 12990 million by 2029, growing at a CAGR of 5.2% from 2023 to 2029. The market is mainly driven by the significant applications of Erythropoietin Drug in various end use industries. The expanding demands from the Anemia, Kidney Disorders and Others,, are propelling Erythropoietin Drug market. Epoetin-alfa, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Darbepoetin-alfa segment is estimated at % CAGR for the next seven-year period.
Global erythropoietin drug market is segmented on the basis of type of product into biosimilars, first generation formulation and second generation formulation. On the basis of application market is segmented as oncology, renal diseases, HIV and other and on the basis of end user they are segmented into hospital and pharmacy.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Erythropoietin Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Erythropoietin Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Erythropoietin Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Erythropoietin Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Erythropoietin Drug covered in this report include Amgen, Johnson & Johnson, Roche, Galenica, Emcure, Kyowa Hakko Kirin, 3SBio, Biocon and LG Life Sciences, etc.
The global Erythropoietin Drug market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio
Biocon
LG Life Sciences
Global Erythropoietin Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Erythropoietin Drug market, Segment by Type:
Epoetin-alfa
Darbepoetin-alfa
Epoetin-beta
Others
Global Erythropoietin Drug market, by Application
Anemia
Kidney Disorders
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Erythropoietin Drug companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Erythropoietin drugs are also known as hematopoietin. It is a glycoprotein hormone that controls erythropoiesis or production of RBC. They are used in treatment of different diseases like cancer, chronic renal diseases,
The global Erythropoietin Drug market size is expected to reach US$ 12990 million by 2029, growing at a CAGR of 5.2% from 2023 to 2029. The market is mainly driven by the significant applications of Erythropoietin Drug in various end use industries. The expanding demands from the Anemia, Kidney Disorders and Others,, are propelling Erythropoietin Drug market. Epoetin-alfa, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Darbepoetin-alfa segment is estimated at % CAGR for the next seven-year period.
Global erythropoietin drug market is segmented on the basis of type of product into biosimilars, first generation formulation and second generation formulation. On the basis of application market is segmented as oncology, renal diseases, HIV and other and on the basis of end user they are segmented into hospital and pharmacy.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Erythropoietin Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Erythropoietin Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Erythropoietin Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Erythropoietin Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Erythropoietin Drug covered in this report include Amgen, Johnson & Johnson, Roche, Galenica, Emcure, Kyowa Hakko Kirin, 3SBio, Biocon and LG Life Sciences, etc.
The global Erythropoietin Drug market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio
Biocon
LG Life Sciences
Global Erythropoietin Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Erythropoietin Drug market, Segment by Type:
Epoetin-alfa
Darbepoetin-alfa
Epoetin-beta
Others
Global Erythropoietin Drug market, by Application
Anemia
Kidney Disorders
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Erythropoietin Drug companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Erythropoietin Drug
1.1 Erythropoietin Drug Market Overview
1.1.1 Erythropoietin Drug Product Scope
1.1.2 Erythropoietin Drug Market Status and Outlook
1.2 Global Erythropoietin Drug Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Erythropoietin Drug Market Size by Region (2018-2029)
1.4 Global Erythropoietin Drug Historic Market Size by Region (2018-2023)
1.5 Global Erythropoietin Drug Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Erythropoietin Drug Market Size (2018-2029)
1.6.1 North America Erythropoietin Drug Market Size (2018-2029)
1.6.2 Europe Erythropoietin Drug Market Size (2018-2029)
1.6.3 Asia-Pacific Erythropoietin Drug Market Size (2018-2029)
1.6.4 Latin America Erythropoietin Drug Market Size (2018-2029)
1.6.5 Middle East & Africa Erythropoietin Drug Market Size (2018-2029)
2 Erythropoietin Drug Market by Type
2.1 Introduction
2.1.1 Epoetin-alfa
2.1.2 Darbepoetin-alfa
2.1.3 Epoetin-beta
2.1.4 Others
2.2 Global Erythropoietin Drug Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Erythropoietin Drug Historic Market Size by Type (2018-2023)
2.2.2 Global Erythropoietin Drug Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Erythropoietin Drug Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Erythropoietin Drug Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Erythropoietin Drug Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Erythropoietin Drug Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Erythropoietin Drug Revenue Breakdown by Type (2018-2029)
3 Erythropoietin Drug Market Overview by Application
3.1 Introduction
3.1.1 Anemia
3.1.2 Kidney Disorders
3.1.3 Others
3.2 Global Erythropoietin Drug Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Erythropoietin Drug Historic Market Size by Application (2018-2023)
3.2.2 Global Erythropoietin Drug Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Erythropoietin Drug Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Erythropoietin Drug Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Erythropoietin Drug Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Erythropoietin Drug Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Erythropoietin Drug Revenue Breakdown by Application (2018-2029)
4 Erythropoietin Drug Competition Analysis by Players
4.1 Global Erythropoietin Drug Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Erythropoietin Drug as of 2022)
4.3 Date of Key Players Enter into Erythropoietin Drug Market
4.4 Global Top Players Erythropoietin Drug Headquarters and Area Served
4.5 Key Players Erythropoietin Drug Product Solution and Service
4.6 Competitive Status
4.6.1 Erythropoietin Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Amgen
5.1.1 Amgen Profile
5.1.2 Amgen Main Business
5.1.3 Amgen Erythropoietin Drug Products, Services and Solutions
5.1.4 Amgen Erythropoietin Drug Revenue (US$ Million) & (2018-2023)
5.1.5 Amgen Recent Developments
5.2 Johnson & Johnson
5.2.1 Johnson & Johnson Profile
5.2.2 Johnson & Johnson Main Business
5.2.3 Johnson & Johnson Erythropoietin Drug Products, Services and Solutions
5.2.4 Johnson & Johnson Erythropoietin Drug Revenue (US$ Million) & (2018-2023)
5.2.5 Johnson & Johnson Recent Developments
5.3 Roche
5.3.1 Roche Profile
5.3.2 Roche Main Business
5.3.3 Roche Erythropoietin Drug Products, Services and Solutions
5.3.4 Roche Erythropoietin Drug Revenue (US$ Million) & (2018-2023)
5.3.5 Galenica Recent Developments
5.4 Galenica
5.4.1 Galenica Profile
5.4.2 Galenica Main Business
5.4.3 Galenica Erythropoietin Drug Products, Services and Solutions
5.4.4 Galenica Erythropoietin Drug Revenue (US$ Million) & (2018-2023)
5.4.5 Galenica Recent Developments
5.5 Emcure
5.5.1 Emcure Profile
5.5.2 Emcure Main Business
5.5.3 Emcure Erythropoietin Drug Products, Services and Solutions
5.5.4 Emcure Erythropoietin Drug Revenue (US$ Million) & (2018-2023)
5.5.5 Emcure Recent Developments
5.6 Kyowa Hakko Kirin
5.6.1 Kyowa Hakko Kirin Profile
5.6.2 Kyowa Hakko Kirin Main Business
5.6.3 Kyowa Hakko Kirin Erythropoietin Drug Products, Services and Solutions
5.6.4 Kyowa Hakko Kirin Erythropoietin Drug Revenue (US$ Million) & (2018-2023)
5.6.5 Kyowa Hakko Kirin Recent Developments
5.7 3SBio
5.7.1 3SBio Profile
5.7.2 3SBio Main Business
5.7.3 3SBio Erythropoietin Drug Products, Services and Solutions
5.7.4 3SBio Erythropoietin Drug Revenue (US$ Million) & (2018-2023)
5.7.5 3SBio Recent Developments
5.8 Biocon
5.8.1 Biocon Profile
5.8.2 Biocon Main Business
5.8.3 Biocon Erythropoietin Drug Products, Services and Solutions
5.8.4 Biocon Erythropoietin Drug Revenue (US$ Million) & (2018-2023)
5.8.5 Biocon Recent Developments
5.9 LG Life Sciences
5.9.1 LG Life Sciences Profile
5.9.2 LG Life Sciences Main Business
5.9.3 LG Life Sciences Erythropoietin Drug Products, Services and Solutions
5.9.4 LG Life Sciences Erythropoietin Drug Revenue (US$ Million) & (2018-2023)
5.9.5 LG Life Sciences Recent Developments
6 North America
6.1 North America Erythropoietin Drug Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Erythropoietin Drug Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Erythropoietin Drug Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Erythropoietin Drug Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Erythropoietin Drug Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Erythropoietin Drug Market Dynamics
11.1 Erythropoietin Drug Industry Trends
11.2 Erythropoietin Drug Market Drivers
11.3 Erythropoietin Drug Market Challenges
11.4 Erythropoietin Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
